NCT04887259 2025-01-27Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AMLLava TherapeuticsPhase 1 Terminated16 enrolled
NCT01517347 2016-10-24Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After TransplantationPeking University People's HospitalPhase NA Terminated90 enrolled